Given the prevalence of onychomycosis and the emergence of laser therapy, these panelists review their approaches to managing onychomycosis, discuss ethical considerations with non-FDA approved modalities and emphasize the importance of...
Given the prevalence of onychomycosis and the emergence of laser therapy, these panelists review their approaches to managing onychomycosis, discuss ethical considerations with non-FDA approved modalities and emphasize the importance of...
Given the prevalence of...